Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma von Olszanski, Anthony J.

Volltext

Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhi... von Hayat, Umar, Elliott, Gary T., Olszanski, Anthony J., Altieri, Dario C.

Volltext

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma von Rasco, Drew W., Medina, Theresa, Corrie, Pippa, Pavlick, Anna C., Middleton, Mark R., Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S., Daud, Adil I., Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J.

Volltext

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 von Drilon, Alexander, Fu, Siqing, Patel, Manish R, Fakih, Marwan, Wang, Ding, Olszanski, Anthony J, Morgensztern, Daniel, Liu, Stephen V, Cho, Byoung Chul, Bazhenova, Lyudmila, Rodriguez, Cristina P, Doebele, Robert C, Wozniak, Antoinette, Reckamp, Karen L, Seery, Tara, Nikolinakos, Petros, Hu, Zheyi, Oliver, Jennifer W, Trone, Denise, McArthur, Katherine, Patel, Rupal, Multani, Pratik S, Ahn, Myung-Ju

Volltext

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors von RINI, Brian I, SCHILLER, Joan H, KIM, Sinil, RIXE, Olivier, FRUEHAUF, John P, COHEN, Ezra E. W, TARAZI, Jamal C, ROSBROOK, Brad, BAIR, Angel H, RICART, Alejandro D, OLSZANSKI, Anthony J, LETRENT, Kristen J

Volltext

Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors von Razak, Albiruni RA, Cleary, James M, Moreno, Victor, Boyer, Michael, Calvo Aller, Emiliano, Edenfield, William, Tie, Jeanne, Harvey, R Donald, Rutten, Annemie, Shah, Manish A, Olszanski, Anthony J, Jäger, Dirk, Lakhani, Nehal, Ryan, David P, Rasmussen, Erik, Juan, Gloria, Wong, Hansen, Soman, Neelesh, Smit, Marie-Anne Damiette, Nagorsen, Dirk, Papadopoulos, Kyriakos P

Volltext

Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study von SCHILLER, Joan H, LARSON, Timothy, VON PAWEL, Joachim, IGNATIUS OU, S.-H, LIMENTANI, Steven, SANDLER, Alan, VOKES, Everett, KIM, Sinil, LIAU, Katherine, BYCOTT, Paul, OLSZANSKI, Anthony J

Volltext

Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma von Gibney, Geoffrey T, Hamid, Omid, Lutzky, Jose, Olszanski, Anthony J, Mitchell, Tara C, Gajewski, Thomas F, Chmielowski, Bartosz, Hanks, Brent A, Zhao, Yufan, Newton, Robert C, Maleski, Janet, Leopold, Lance, Weber, Jeffrey S

Volltext

Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors von Zibelman, Matthew, Wong, Yu-Ning, Devarajan, Karthik, Malizzia, Lois, Corrigan, Alycia, Olszanski, Anthony J., Denlinger, Crystal S., Roethke, Susan K., Tetzlaff, Colleen H., Plimack, Elizabeth R.

Volltext

Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Oral CP-868,596, a Highly Specific Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor in Patients... von Lewis, Nancy L, Lewis, Lionel D, Eder, Joseph P, Reddy, Nandi J, Guo, Feng, Pierce, Kristen J, Olszanski, Anthony J, Cohen, Roger B

Volltext

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) von Mitchell, Tara C, Hamid, Omid, Smith, David C, Bauer, Todd M, Wasser, Jeffrey S, Olszanski, Anthony J, Luke, Jason J, Balmanoukian, Ani S, Schmidt, Emmett V, Zhao, Yufan, Gong, Xiaohua, Maleski, Janet, Leopold, Lance, Gajewski, Thomas F

Volltext

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors von Juric, Dejan, Barve, Minal, Vaishampayan, Ulka, Roda, Desamparados, Calvo, Aitana, Jañez, Noelia Martinez, Trigo, Jose, Greystoke, Alastair, Harvey, R. Donald, Olszanski, Anthony J., Opyrchal, Mateusz, Spira, Alexander, Thistlethwaite, Fiona, Jiménez, Begoña, Sappal, Jessica Huck, Kannan, Karuppiah, Riley, Jason, Li, Cheryl, Li, Cong, Gregory, Richard C., Miao, Harry, Wang, Shining

Volltext

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy von Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John M., Gajewski, Thomas F., Chen, Lisa, Gorski, Kevin S., Anderson, Abraham A., Diede, Scott J., Lassman, Michael E., Gansert, Jennifer, Hodi, F. Stephen, Long, Georgina V.

Volltext

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors von Papadopoulos, Kyriakos P, Gluck, Larry, Martin, Lainie P, Olszanski, Anthony J, Tolcher, Anthony W, Ngarmchamnanrith, Gataree, Rasmussen, Erik, Amore, Benny M, Nagorsen, Dirk, Hill, John S, Stephenson, Jr, Joe

Volltext

Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma von Shoushtari, Alexander N, Olszanski, Anthony J, Nyakas, Marta, Hornyak, Thomas J, Wolchok, Jedd D, Levitsky, Victor, Kuryk, Lukasz, Hansen, Thomas B, Jäderberg, Magnus

Volltext

Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors von Infante, Jeffrey R, Dees, E Claire, Olszanski, Anthony J, Dhuria, Shyeilla V, Sen, Suman, Cameron, Scott, Cohen, Roger B

Volltext

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors von Gutierrez, Martin, Moreno, Victor, Heinhuis, Kimberley M, Olszanski, Anthony J, Spreafico, Anna, Ong, Michael, Chu, Quincy, Carvajal, Richard D, Trigo, José, Ochoa de Olza, Maria, Provencio, Mariano, De Vos, Filip Yves, De Braud, Filippo, Leong, Stephen, Lathers, Deanne, Wang, Rui, Ravindran, Palani, Feng, Yan, Aanur, Praveen, Melero, Ignacio

Volltext

Annals of Surgical Oncology Practice Guidelines Series: Adjuvant and Neoadjuvant Therapy for Melanoma von Farma, Jeffrey M, Olszanski, Anthony J, Messina, Jane L, Sondak, Vernon K

Volltext

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A02+ patients: a phase 1 trial von Hong, David S., Van Tine, Brian A., Biswas, Swethajit, McAlpine, Cheryl, Johnson, Melissa L., Olszanski, Anthony J., Clarke, Jeffrey M., Araujo, Dejka, Blumenschein, George R., Kebriaei, Partow, Lin, Quan, Tipping, Alex J., Sanderson, Joseph P., Wang, Ruoxi, Trivedi, Trupti, Annareddy, Thejo, Bai, Jane, Rafail, Stavros, Sun, Amy, Fernandes, Lilliam, Navenot, Jean-Marc, Bushman, Frederic D., Everett, John K., Karadeniz, Derin, Broad, Robyn, Isabelle, Martin, Naidoo, Revashnee, Bath, Natalie, Betts, Gareth, Wolchinsky, Zohar, Batrakou, Dzmitry G., Van Winkle, Erin, Elefant, Erica, Ghobadi, Armin, Cashen, Amanda, Grand’Maison, Anne, McCarthy, Philip, Fracasso, Paula M., Norry, Elliot, Williams, Dennis, Druta, Mihaela, Liebner, David A., Odunsi, Kunle, Butler, Marcus O.

Volltext

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy von Ribas, Antoni, Dummer, Reinhard, Puzanov, Igor, VanderWalde, Ari, Andtbacka, Robert H.I., Michielin, Olivier, Olszanski, Anthony J., Malvehy, Josep, Cebon, Jonathan, Fernandez, Eugenio, Kirkwood, John M., Gajewski, Thomas F., Chen, Lisa, Gorski, Kevin S., Anderson, Abraham A., Diede, Scott J., Lassman, Michael E., Gansert, Jennifer, Hodi, F. Stephen, Long, Georgina V.

Volltext